multi source·4h ago·3 sources analyzed
Trump signs order to research psychedelic drug for PTSD treatment
An executive order aims to facilitate research into the psychedelic drug ibogaine for mental health treatment. This move is part of broader efforts to explore alternative therapies for conditions like PTSD. (sources: cbsnews, nytimes, reuters)
Image: cbsnews
ModernAction Briefing
The executive order signed by Trump is designed to accelerate research into ibogaine, a psychedelic drug used abroad for treating PTSD and other mental health issues.
- The executive order will promote research into ibogaine's effectiveness for PTSD and depression.
- Officials indicated that the order is part of a broader initiative to explore alternative mental health treatments.
- The move is expected to ease existing restrictions on psychedelic drugs.
Why it matters
This initiative could lead to new treatment options for individuals suffering from PTSD and other mental health conditions.
No specific legislation identified for action yet.